Free Trial

Ethic Inc. Has $1.16 Million Position in Genpact Limited $G

Genpact logo with Computer and Technology background

Key Points

  • Ethic Inc. sold 6,687 shares of Genpact Limited, reducing its holdings by 22.6% in the first quarter, leaving it with 22,965 shares valued at approximately $1,161,000.
  • Several hedge funds have altered their positions in Genpact, with Stifel Financial Corp increasing its stake by 1%, reflecting overall significant institutional interest with 96.03% of the stock owned by institutional investors.
  • Genpact has recently announced a quarterly dividend of $0.17, which will be paid on September 25th, representing an annualized yield of 1.5%.
  • Need better tools to track Genpact? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Ethic Inc. cut its position in shares of Genpact Limited (NYSE:G - Free Report) by 22.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 22,965 shares of the business services provider's stock after selling 6,687 shares during the quarter. Ethic Inc.'s holdings in Genpact were worth $1,161,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of G. Coppell Advisory Solutions LLC grew its holdings in shares of Genpact by 529.5% in the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after acquiring an additional 503 shares during the last quarter. Cornerstone Planning Group LLC acquired a new stake in Genpact during the 1st quarter worth about $27,000. Richardson Financial Services Inc. purchased a new position in shares of Genpact in the first quarter worth approximately $35,000. GeoWealth Management LLC boosted its stake in Genpact by 199.0% in the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after purchasing an additional 583 shares during the period. Finally, Global X Japan Co. Ltd. purchased a new position in Genpact during the 1st quarter worth approximately $57,000. Institutional investors own 96.03% of the company's stock.

Genpact Stock Performance

Shares of Genpact stock traded up $0.0450 during trading on Monday, reaching $45.3550. The company's stock had a trading volume of 126,659 shares, compared to its average volume of 1,616,800. The business's fifty day moving average price is $44.06 and its 200-day moving average price is $46.83. Genpact Limited has a one year low of $37.82 and a one year high of $56.76. The firm has a market cap of $7.90 billion, a price-to-earnings ratio of 15.07, a price-to-earnings-growth ratio of 1.56 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.03. The company had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.Genpact's revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, equities research analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be given a $0.17 dividend. The ex-dividend date is Thursday, September 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.5%. Genpact's payout ratio is 22.59%.

Analyst Ratings Changes

G has been the subject of several recent analyst reports. Mizuho raised their target price on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Wall Street Zen upgraded Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th. Needham & Company LLC raised their price target on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Deutsche Bank Aktiengesellschaft started coverage on shares of Genpact in a research note on Thursday, July 17th. They issued a "hold" rating and a $47.00 price objective on the stock. Finally, Robert W. Baird decreased their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Three investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Genpact presently has an average rating of "Hold" and a consensus price target of $52.29.

Check Out Our Latest Stock Report on G

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines